Based on the Bioventix PLC stock forecast from 0 analysts, the average analyst target price for Bioventix PLC is not available over the next 12 months. Bioventix PLC’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bioventix PLC is Slightly Bullish , which is based on 8 positive signals and 5 negative signals. At the last closing, Bioventix PLC’s stock price was EUR 43.60. Bioventix PLC’s stock price has changed by -1.36% over the past week, +2.35% over the past month and -2.24% over the last year.
No recent analyst target price found for Bioventix PLC
No recent average analyst rating found for Bioventix PLC
Company Overview Bioventix PLC
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. It also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom. Read Less
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene ...Read More
Frequently Asked Questions About Bioventix PLC (51B:F) Stock
Stock Target Advisor's fundamental analysis for Bioventix PLC's stock is Slightly Bullish .
51B:F stock's dividend yield is 3.97%.
Our analysis grades 51B:F stock's dividend yield at C. This means that 51B:F stock's dividend yield is above 75% of the stocks in the Biotechnology sector in the F exchange.
Based on this 51B:F may be a average dividend stock for its sector.
Unfortunately we do not have enough data on 51B:F's stock to indicate what its average analyst target is.
51B:F stock's Price/Earning ratio is 24.46.
Our analysis grades 51B:F stock's Price / Earning ratio at F. This means that 51B:F stock's Price/Earning ratio is above 63% of the stocks in the Biotechnology sector in the F exchange.
Based on this 51B:F may be a overvalued for its sector.
The last closing price of 51B:F's stock was EUR 43.60.
The most recent market capitalization for 51B:F is EUR 0.24B.
Unfortunately we do not have enough analyst data on 51B:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Bioventix PLC's stock.
As per our most recent records Bioventix PLC has 12 Employees.
Bioventix PLC's registered address is 7 Romans Business Park, Farnham, United Kingdom, GU9 7SX.
You can get more information about it from Bioventix PLC's website at https://www.bioventix.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Bioventix PLC (51B:F) Stock
Stock Target Advisor's fundamental analysis for Bioventix PLC's stock is Slightly Bullish .
51B:F stock's dividend yield is 3.97%.
Our analysis grades 51B:F stock's dividend yield at C. This means that 51B:F stock's dividend yield is above 75% of the stocks in the Biotechnology sector in the F exchange.
Based on this 51B:F may be a average dividend stock for its sector.
Unfortunately we do not have enough data on 51B:F's stock to indicate what its average analyst target is.
51B:F stock's Price/Earning ratio is 24.46.
Our analysis grades 51B:F stock's Price / Earning ratio at F. This means that 51B:F stock's Price/Earning ratio is above 63% of the stocks in the Biotechnology sector in the F exchange.
Based on this 51B:F may be a overvalued for its sector.
The last closing price of 51B:F's stock was EUR 43.60.
The most recent market capitalization for 51B:F is EUR 0.24B.
Unfortunately we do not have enough analyst data on 51B:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Bioventix PLC's stock.
As per our most recent records Bioventix PLC has 12 Employees.
Bioventix PLC's registered address is 7 Romans Business Park, Farnham, United Kingdom, GU9 7SX.
You can get more information about it from Bioventix PLC's website at https://www.bioventix.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 51B:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
